Blood-based biomarkers GFAP/UCH-L1 for the diagnosis of mild traumatic brain injury (mTBI): a single-center implementation experience
Marc Maegele, Lucas Breidenbach, Janina Kaufmann, Yunus Keles, Eberhard Uhl, Peter Schroeer · 2026
Read Blood-based biomarkers GFAP/UCH-L1 for the diagnosis of mild traumatic brain injury (mTBI): a single-center implementation experience by Marc Maegele, Lucas Breidenbach, Janina Kaufmann, Yunus Keles, Eberhard Uhl, Peter Schroeer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13294316.txt.
Description
Marc Maegele and colleagues report first hospital use of a blood test for mild brain injury in a 2026 study. Care in the ER leans on head scans that cost time and add radiation dose. Adults seen in Cologne from November 2023 to April 2024 had suspected mild injury and coma scores of 13 to 15. Each got a head scan plus blood tests for GFAP and UCH-L1 within 12 hours, for 320 patients in all.
Blood marks were high in 261 patients, or 82%, while scans found injury in only 29, or 9%, in the reported shares. Paired marks caught 97% of scan-proved injury and gave a 98% rate for ruling injury out when low. Safe scan cuts are the prize, pending wider checks.
Catalog record
| CREATOR | Marc Maegele, Lucas Breidenbach, Janina Kaufmann, Yunus Keles, Eberhard Uhl, Peter Schroeer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30990 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |